3/1/2023
RedChip Logo

RedChip Companies

Weekly Newsletter
 

BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic

BullFrog AI (Nasdaq: BFRG), a digital technology company using machine learning to usher in a new era of precision medicine, today announced a co-development arrangement with the J. Craig Venter Institute (JCVI), a world-leading institution in genomics research and innovation, for the design and validation of a synthetic HSV-1 (herpes simplex type 1) virus particle targeting colorectal cancer.

For more information, visit www.bullfrogai.com

 
See More Info
 
 
 

Graphex Technologies Update: Global Expansion Progress and Business Strategy Highlights

Graphex Technologies, a wholly owned U.S. subsidiary of Graphex Group Limited (NYSE American: GRFX), a global leader in mid-stream processing of specialized natural graphite used for electric vehicle (EV) Lithium-ion (Li-ion) batteries, provided an update that reflects on milestones achieved and objectives for 2023.

 
Learn More
   

Sidus Space Secures Additional Launches with SpaceX

Sidus Space (Nasdaq: SIDU), a Space-as-a-Service company focused on mission critical hardware manufacturing combined with commercial satellite design, manufacture, launch, and data collection, announced it has signed an agreement with SpaceX to launch on Transporter missions manifested for 2024 and 2025.

 
Learn More
 

Reviv3 Accelerates European Rollout of AXIL Performance Hearing Products with New Distributor in Switzerland

Reviv3 Procare Company (OTCQB: RVIV), an emerging global e-commerce consumer products company, entered into an agreement with TACFORCE AG for distribution of AXIL hearing enhancement and protection products in Switzerland. Founded in 2009, TACFORCE AG is a supplier of tactical equipment and accessories to police, special units, military, rescue organizations and outdoors professionals.

 
Learn More
 

Permex Petroleum Provides Updated Reserve Report Confirming 27 Million Barrels of Oil Equivalent on its Permian Basin Assets

Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF), an independent energy company engaged in the acquisition, exploration, development and production of oil and natural gas properties on private, state and federal land in the United States, received an updated independent reserve evaluation from MKM Engineering, effective November 21, 2022, with total proved and probable reserves of 27.0 million BOE and PV10 value of $428 million, an increase of 48% year-over-year.

 
Learn More
 

 
 

Upcoming Events

1

March

2023

NASDAQ: IINN - Inspira Technologies
11:00am Eastern
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure.
 
Sign Up
 

9

March

2023

NASDAQ: STSS - Sharps Technology
4:15pm Eastern
Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation.
 
Sign Up
 

14

March

2023

NASDAQ: IMNM - Immunome
4:15pm Eastern
Immunome was founded to advance the discovery and development of antibody-based drugs. Our proprietary antibody Discovery Engine identifies novel therapeutic antibodies, and their antigen targets, by leveraging the most highly-educated components of the B cells from patients who have learned to fight off their disease.
 
Sign Up
 

15

March

2023

NASDAQ: BIVI - BioVie
4:15pm Eastern
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
Sign Up
 

21

March

2023

NYSE American: ZOM - Zomedica
4:15pm Eastern
Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians.
 
Sign Up
 

23

March

2023

NASDAQ: APM - Aptorum Group
4:15pm Eastern
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs.
 
Sign Up
 

28

March

2023

NASDAQ: BFRG - BullFrog AI
4:15pm Eastern
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development.
 
Sign Up
 

30

March

2023

NASDAQ: SIDU - Sidus Space
4:15pm Eastern
Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers.
 
Sign Up
 
 
 

Archive Events

22

February

2023

NASDAQ: ASPI - ASP Isotopes
Meeting Duration 23 minutes
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Watch Replay
 

22

February

2023

OTCQB: AMNI - American Noble Gas
Meeting Duration 16 minutes
American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks.
 
Watch Replay
 

21

February

2023

NASDAQ: RCRT - Recruiter.com
Meeting Duration 44 minutes
Recruiter.com is an on-demand recruiting platform providing flexible talent acquisition solutions that scale from startups to the Fortune 100.
 
Watch Replay
 

15

February

2023

NYSE American: GNS - Genius Group
Meeting Duration 74 minutes
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market.
 
Watch Replay
 

9

February

2023

NASDAQ: KWE - KWESST Micro Systems
Meeting Duration 38 minutes
KWESST Micro Systems develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries.
 
Watch Replay
 

8

February

2023

NASDAQ: GENE - Genetic Technologies Limited
Meeting Duration 28 minutes
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Replay
 

6

February

2023

NASDAQ: ARDS - Aridis Pharmaceuticals
Meeting Duration 62 minutes
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics.
 
Watch Replay
 

1

February

2023

NASDAQ: BIVI - BioVie
Meeting Duration 46 minutes
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
Watch Replay
 

31

January

2023

OTC: EBZT - Everything Blockchain
Meeting Duration 37 minutes
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies.
 
Watch Replay
 

26

January

2023

NASDAQ: RVPH - Reviva Pharmaceutical
Meeting Duration 46 minutes
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.
 
Watch Replay
 
 
 

Lesson of the Week

The importance of leadership.

 
Learn More
 
 
 
 

RedChip TV

This Week on RedChip TV: Three Unique Small Cap Companies Revolutionizing Their Industries

American Noble Gas: Explorer of Helium-Rich, Natural Gas

Tuntise: Providing the Best Mining and Exploration Services

Rail Vision: Revolutionizing Rail Safety Using A.I.

Everything Blockchain: Real-World Blockchain Solutions for Everyone

GenEmbryomics: Providing the World's First Genetic Screening for IVF

Aptorum: A Rare, Revenue-Generating Biopharma Company

Aridis Pharmaceuticals Reports Positive Top-Line Data for Lead Phase 3 Program

Everything Blockchain: Using Diverse Revenue Streams to Provide a Compelling Investment Opportunity

Zomedica: Improving Pet Care & Providing New Business Opportunities for Vets

 
 

MidSouth Week in Review

The S&P had its worst performance of the year on Tuesday with a 2.0% decline.

 
Learn More
 

You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
© 2023 RedChip , All rights reserved